A quick overview of other recent news relating to diabetes management and/or CGMs.

A look at the company's dramatic share price drop, iLet patient numbers, CGM partnership with Abbott & the outlook for rollout in the UK/EU. Beta Bionics, maker of the iLet® Bionic Pancreas, has experienced a turbulent start to 2026 as its share price slid amid concerns over lower than expected numbers of new-starts and patient-reported safety patterns raising questions. iLet user base & new patient starts Image courtesy of Beta Bionics Adoption data from Beta Bionics show ra

What longer-wear monitoring, fewer sensor changes and tighter integration could mean for future CGM and pump choices. Image courtesy of Senseonics Senseonics has announced that their first commercial patient is now using the Eversense 365 CGM integrated with Sequel MedTech’s twiist™ hybrid-closed loop insulin delivery system, marking an important step in the development of longer-term diabetes technology. This is the first time a 365-day CGM has been paired with a hybrid-clos

Details of Insulet's long-term vision and new details about Omnipod 6, alongside upgrades to existing systems and a fully closed-loop option for people with type 2 diabetes.

We reflect on Dexcom's performance in 2025 and get up-to-date with news of their plans for a G8 sensor and international expansion

UK researchers have shown that screening children for type 1 diabetes can detect the condition early, preventing emergencies and enabling access to treatments that delay the need for insulin. A major UK research programme has shown that screening children for type 1 diabetes (T1D) can detect the condition years before symptoms appear—dramatically reducing the risk of life-threatening emergencies at diagnosis and giving families time to prepare, plan, and access emerging treat

Researchers in the UK and Belgium have identified a previously unknown genetic cause of a rare form of diabetes that develops in newborn babies, offering new insight into how insulin-producing cells function in early life. The discovery was made by scientists at the University of Exeter, working alongside colleagues at Belgium’s Université Libre de Bruxelles (ULB). Their research shows that mutations in a little-known gene, TMEM167A, can cause insulin-producing cells in the p

A recent update to the Libre 3 app in the US now enables users to snap their meal to learn how their glucose will change.

Image courtesy of Medtronic Inc. Approval of MiniMed Go brings connectivity for 780G. Medtronic has received FDA clearance for a new mobile app designed to connect its smart insulin pens with glucose sensing technology developed by Abbott, marking another step towards more connected diabetes management for people who do not use a pump. The app, called MiniMed™ Go, links Medtronic’s smart insulin pens with the Instinct sensor by Abbott, enabling users to view glucose levels al

A new development from CamDiab Ltd brings closed-loop technology closer to reality. Following approval, CamDiab has announced progress towards what it describes as the world’s first commercially available fully closed-loop insulin delivery algorithm — a system designed to operate without carbohydrate counting or pre-meal bolusing. For PWD, this marks a potentially significant shift. While existing hybrid closed-loop systems have already transformed glucose management for many

Find out about Roche's Accu-Chek CGM. We outline the key features and give you a comparison with similar medtech so that you can evaluate...

News that Roche are to invest $550 million in US manufacturing hub to produce CGMs.

Find out about Sinocare's CGM. We outline the key features and give you a comparison with similar medtech so that you can evaluate if...

Medtronic's Simplera CGM system overview.

Overview of the Sibionics GS1 CGM with features and comparison with similar medtech.

News of award for Eversense 365 implantable CGM.

A new partnership between Senseonics and twist will enable new option for automated insulin delivery (AID) system.

A recent study suggests that airplane flights could affect the performance of insulin pumps.

News of FDA approval for Medtroinic's Simplera Sync sensor that now pairs with the MiniMed™ 780G insulin pump,

Image courtesy of Dexcom Inc. The FDA have now approved the new Dexcom G7 15 day CGM in the US. With the grace period of 12 hours, it...